Characterisation of the genomes of brain metastases
<p>Brain metastases are generally associated with a poor prognosis. The number of metastases, location and control of extracranial disease typically influences the management of patients. Treatment options are currently limited and are dependent on the clinical context. Interventions include s...
Κύριος συγγραφέας: | Ulahannan, D |
---|---|
Άλλοι συγγραφείς: | Tomlinson, I |
Μορφή: | Thesis |
Έκδοση: |
2015
|
Παρόμοια τεκμήρια
-
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
ανά: Marcin Nicoś, PhD, κ.ά.
Έκδοση: (2022-12-01) -
Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brain.
ανά: Ursula Just, κ.ά.
Έκδοση: (2024-01-01) -
Clinicopathologic and genomic characterizations of brain metastases using a comprehensive genomic panel
ανά: Duna H. Barakeh, κ.ά.
Έκδοση: (2022-11-01) -
Genomic landscape of the immune microenvironments of brain metastases in breast cancer
ανά: Wei-cheng Lu, κ.ά.
Έκδοση: (2020-08-01) -
Prevention of Brain Metastases
ανά: Joseph A. Bovi
Έκδοση: (2018-09-01)